Quarterly Results

ARVAYA HEALTHCARE LTD.

NSE : NABSE : 524723ISIN CODE : INE491D01017Industry : TradingHouse : Private
BSE94.390 (0 %)
PREV CLOSE ( ) 94.39
OPEN PRICE ( ) 94.39
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 175
TODAY'S LOW / HIGH ( )94.39 94.39
52 WK LOW / HIGH ( ) 24.1594.39
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2026
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
Net Sales
91.13
0.04
Total Expenditure
77.24
1.89
PBIDT (Excl OI)
13.89
-1.85
Other Income
12.96
0.47
Operating Profit
26.85
-1.38
Interest
4.12
0.1
Exceptional Items
NA
-0.02
PBDT
22.73
-1.5
Depreciation
6.16
0.00
Profit Before Tax
16.57
-1.5
Tax
1.9
0.55
Provisions and contingencies
NA
NA
Profit After Tax
14.67
-2.05
Extraordinary Items
NA
NA
Prior Period Expenses
NA
NA
Other Adjustments
NA
NA
Net Profit
14.67
-2.05
Minority Interest
-2.01
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
Consolidated Net Profit
12.66
-2.05
Equity Capital
480.22
30
Face Value (IN RS)
10
10
Reserves
NA
NA
Calculated EPS
0.26
-0.68
Calculated EPS (Annualised)
1.05
-2.73
No of Public Share Holdings
33318178
2767721
% of Public Share Holdings
69.38
92.26
 
NA
NA
PBIDTM% (Excl OI)
15.24
-4625
PBIDTM%
29.46
-3450
PBDTM%
24.94
-3750
PBTM%
18.18
-3750
PATM%
16.09
-5125
 
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.